SARS-CoV-2 real-time PCR diagnostics
ViroQ® & ViroQ® Rapid SARS-CoV-2

Awarded the Innovation Prize 2021 – our real-time PCR tests ViroQ® & ViroQ® Rapid SARS-CoV-2! We have developed our kits for the specific detection of viral RNA, gene E and RdRP of SARS-CoV-2 in respiratory samples.

To offer you maximum safety, our CE IVD-certified rapid tests check whether there is sufficient test material in the swabs. You will only receive a negative result if no COVID-19 can actually be detected!

  • Fast: you get your result in less than 60 (Rapid variant) or 90 minutes.
  • Safe: sample quality check – no false negative results
  • Convenient: easy handling, ready-to-use reagents
  • Flexible: compatible with common real-time cyclers
safe results in COVID-19 typing
  • FAQ
  • Product
  • Bundle
  • REF
  • Reg. Status
  • Compatibility
  • ViroQ® Rapid SARS-CoV-2
  • 96 tests
  • 728263
  • IVD certified
  • Cycler Compatibility Check
    Cycler Compatibility Check
  • ViroQ® Rapid SARS-CoV-2
  • 480 tests
  • 728264
  • IVD certified
  • Cycler Compatibility Check
    Cycler Compatibility Check
  • ViroQ® SARS-CoV-2
  • 96 tests
  • 728250
  • IVD certified
  • Cycler Compatibility Check
    Cycler Compatibility Check
  • ViroQ® SARS-CoV-2
  • 480 tests
  • 728251
  • IVD certified
  • Cycler Compatibility Check
    Cycler Compatibility Check
  • Simple workflow

    Ready-to-use standard reagents and a one-step PCR run provide rapid results. The kits also include a control of a human universally expressed gene to help verify that sufficient cellular material is present in the sample for meaningful results.

    The three fluorescent dyes used are compatible with the common real-time cyclers – tested on QuantStudio 6 (Thermo Fiscer Scientific), CFX 96TM (Bio-Rad) and Lightcycler® 480 (Roche).

    The evaluation is performed via the hardware manufacturer's software.

    Instructions for Use
    ViroQ® SARS-CoV-2 V04/2020 320.32 KB 2020-10-05
    ViroQ® SARS-CoV-2 V04/2020 234.27 KB 2020-10-05
    ViroQ® SARS-CoV-2 V06/2022 252.25 KB 2022-03-02
    ViroQ® SARS-CoV-2 V06/2022 278.22 KB 2022-03-02
    ViroQ® SARS-CoV-2 V04/2020 190.17 KB 2020-10-05
    ViroQ® SARS-CoV-2 V05/2021 459.19 KB 2021-10-19
    ViroQ® SARS-CoV-2 V04/2020 279.81 KB 2020-10-05
    ViroQ® SARS-CoV-2 V05/2021 354.80 KB 2021-09-21
    ViroQ® SARS-CoV-2 V03/2020 232.69 KB 2020-08-17
    ViroQ® SARS-CoV-2 V05/2021 320.66 KB 2021-09-21
    ViroQ® SARS-CoV-2 V03/2020 238.97 KB 2020-08-17
    ViroQ® SARS-CoV-2 V04/2020 315.96 KB 2020-10-05
    MSDS ViroQ® Enzyme V12/2020 143.69 KB 2020-12-22
    MSDS ViroQ® Solvent V12/2020 185.41 KB 2020-12-22
    MSDS ViroQ® Solvent V12/2020 184.78 KB 2020-12-22
    MSDS ViroQ® Enzyme V12/2020 171.18 KB 2020-12-22
    Product Flyer

    There is one kit size for 100 tests and one for 500 tests.

    The test should be able to be performed with all RNA isolation kits. We tested the kit with the isolation kits from Qiagen and Sigma-Aldrich.

    The test runs on common real-time cyclers. Only RNA isolation kits are required.

    • RT-PCR reaction tubes with caps or foils

    • DEPC H2O / Aqua dest. / WFI (Ampuwa®)

    • Piston pipettes (0,5 – 1000 μl) and tips

    There is no need for a software, the labs do an excel based data analysis based on CT values.

    So far, we tested nasopharyngeal swabs at BAG and in customer labs.

    Blood and stool samples have a higher risk of PCR failure due to "common inhibitors" and usually lower virus titres and are, therefore, not recommended.

    The test is CE IVD certified.

    We have an extensive stock. In addition, thanks to short lead times, we can also realize larger orders in about 3 to 4 weeks.

    As an alternative to our real-time PCR test, you can use our SARS-CoV-2 antigen rapid test. By taking a nasal swab (which should always be prepared by qualified personnel), a result can be read quickly and easily on site within 15 minutes.
    Important: Depending on the time of the swab, a negative result does not completely exclude an infection. However, a positive result indicates an infection and should be verified by PCR testing. As access control to vulnerable groups of people and in areas with many contact points, the rapid test is therefore an ideal indicator.

    Currently, we have focused on the detection of COVID-19, as it is detectable immediately after infection. This allows us to very quickly localize infected persons as carriers of the virus. Antibodies are built at the earliest from the second week of infection. Therefore, these tests are not effective in the first, highly infectious phase of the disease.

    However, we are working with partners on a rapid antibody test. This is intended to identify recovered patients reliably. The same applies to the estimated number of untested persons who have produced antibodies with only minor symptoms or without findings and are therefore immunized.

    The larger hospitals have an automated PCR analysis line. We took this into consideration during development.

    Since the typical automated liquid handling (ALH) systems are very flexible, the kit runs on the most common ALH or integrated automated PCR assay systems such as Qiasymphony and Hologic.


    According to current experience, an infection with SARS-CoV-2 (COVID-19) causes only common cold symptoms in four out of five infections. However, in patients with a weakened immune system or corresponding chronic illnesses, disease patterns with a more serious course – even death – can occur. If the virus spreads too quickly, intensive medical care for patients cannot be guaranteed throughout the country.

    Against the massive spread of the coronavirus SARS-CoV-2, our reliable CE IVD certified ViroQ® SARS-CoV-2 rapid test helps to locate infected persons safely. This is the only way to prevent the unchecked spread of the virus.

    Variant of SARS-CoV-2 Omicron / B.1.1.529 is also covered by our ViroQ® kits.

    ViroQ® Rapid SARS-Cov-2!

    Do you want to get results even faster without compromising on quality? We have made ViroQ® SARS-Cov-2 even more efficient with a specially optimized PCR protocol. With ViroQ® Rapid SARS-CoV-2 valid results are available after less than 60 minutes. That means one more test run per day! The PCR protocol is applicable to both kits.

    Icon Benefit Box
    • one-step real-time PCR method – get your result in less than 60 (rapid variant) or 90 minutes
    • sample quality control – no false negative results
    • safe handling, ready-to-use reagents
    • save logistics costs – transport ViroQ® at room temperature
    Benedikt Hampen
    Product Manager
    HLA Diagnostics & Infectiology
    +49 6404 925-412
    +49 1517 2833148
    Benedikt Hampen, Product Manager
    Beginn eines Zitats

    Our ViroQ® & ViroQ® Rapid SARS-CoV-2 tests verifies whether there is sufficient sample material in the swabs. You will only receive correct negative results if no SARS-CoV-2 can actually be detected! False negative results – due to insufficient samples – are thus avoided. Furthermore, we can send our test kits uncooled. This saves you considerable logistics costs."

    Abschluss eines Zitats

    Fast and valid results

    False negative results, due to insufficient sampling with too little cell material, are excluded by this test. In the ViroQ® and ViroQ® Rapid tests, the detection of a human, universally occurring gene in cells shows whether sufficient cell material is available for valid results.

    We have also thought about the logistics costs: To keep them as low as possible, both test kits can be shipped uncooled. A control temperature of -20 degrees Celsius is only necessary during storage.

    Independent of supplier

    With our kits you remain independent of dedicated providers – they work with common RNA-Isolation kits and common real time cyclers. The test results are available in only 90 minutes – with ViroQ® Rapid SARS-CoV-2 (thanks to the optimized PCR protocol) in less than 60 minutes.

    Fast one-step real-time PCR

    The ViroQ®-Line is designed for specific detection of viral RNA gene E and RdRP of SARS-CoV-2 in respiratory samples. In our test kits the RNA from SARS-CoV-2 (COVID-19) is converted to cDNA in a one-step PCR procedure. This cDNA is then amplified in the same real-time PCR protocol.

    The kit consists of the following components:

    1. tube Mastermix: transcription + amplification
    2. tube Reconstitution buffer
    3. tube Primer-Probe Mixture:

    Colour 1: Virus gene 1 (FAM)
    Colour 2: Virus gene 2 (HEX)
    Colour 3: Cell control (CFR610) (housekeeping gene)
    4. tube Positive Control (SARS-CoV-2 Positive Control)

    "FastQ® RHD fetal plus kit reliably analyses the genetic predisposition of a fetus for the expression of a rhesus D type. Of particular note is that this kit eliminates the need to perform a restriction digest, which contributes to a faster and easier procedure. The kit includes two internal controls that indicate proper sample processing, is particularly robust and has not produced any inconclusive results since its introduction 6 months ago. "

    R. Friedrich
    Research Associate Molecular Diagnostics and NGS alphaomega Laboratories, Leipzig, Germany
    Icon Testimonial
    What our customers say...

    "I came back from the lab with the results of the BAG-SARS-Flu A/B kit and found that my young son had contracted influenza B. I was very pleased with the results. Even though the result was not encouraging, I was thrilled with the test kit itself! It gave us enough time to get medicine and inform the KiTa. He actually spiked a fever in the evening and we were well prepared. So the kit had real value for me personally and may have prevented worse throughout the KiTa."

    Dr. Jörg Hucklenbroich
    Research & Development, BioEcho
    Icon Testimonial
    What our customers say...
    Copyright 2023. All Rights Reserved.

    May we offer cookies to you?

    By clicking "Accept all", you agree to cookies being stored on your local device, according to the requirements of the GDPR. This improves navigation on the site, video content can be displayed and we can anonymously analyse whether the pages are being used as intended.


    Domain name:
    Expiry: 30 days
    Storage location: Localstorage
    Description: Saves the privacy level settings from the Cookie Consent Tool "Privacy Manager".


    Domain name:
    Expiry: 30 days
    Storage location: Localstorage
    Description: Stores the retention period of the privacy level settings from the Cookie Consent Tool "Privacy Manager".


    Domain name:
    Expiry: -
    Storage location: Localstorage
    Description: Saves how often the animation of the start page has run. It is no longer displayed after x runs.


    Domain name:
    Expiry: -
    Storage location: Localstorage
    Description: Saves the position in a questionnaire on certain landing pages


    Domain name:
    Expiry: After end of session
    Storage location: Cookies
    Description: Stores technically necessary information about the current session


    Domain name:
    Expiry: After end of session
    Storage location: Cookies
    Description: Created to block CSFR attack on the current session.
    You are using an outdated browser. The website may not be displayed correctly. Close